The methanol extract also exhibited moderate inhibition of butyrylcholinesterase (BChE), with an IC50 of 122 μg/mL, suggesting possible applications in Alzheimer’s disease therapy. This evidence concerns the gene BCHE and early-onset autosomal dominant Alzheimer disease.